- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer - Abstract
September 28, 2011
A pilot study on understanding the journey of advanced prostate cancer patients - Abstract
September 28, 2011
Preoperative weight change and risk of adverse outcome following radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database - Abstract
September 28, 2011
Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis - Abstract
September 28, 2011
Inflammation marker may guide prognosis for prostate cancer
September 28, 2011
Hormone therapy for prostate cancer and the risk of stroke: A 5-year follow-up study - Abstract
September 27, 2011
Information needs of men on androgen deprivation therapy - Abstract
September 27, 2011
Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer - Abstract
September 27, 2011
Estrogens and prostate cancer: Etiology, mediators, prevention, and management - Abstract
September 27, 2011
The timing and extent of androgen deprivation therapy for prostate cancer: Weighing the clinical evidence - Abstract
September 27, 2011
New hormonal therapies for castration-resistant prostate cancer - Abstract
September 27, 2011
Androgens and prostate cancer bone metastases: Effects on both the seed and the soil - Abstract
September 27, 2011
Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy - Abstract
September 27, 2011
Editor's Commentary - Patient expectations on sexual function following prostate cancer treatment
September 27, 2011
Complications and postoperative events after cryosurgery for prostate cancer - Abstract
September 26, 2011